Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL-Reference-Cited by-同舟云学术

Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL

Published:2017-10-26 Issue:4 Volume:183 Page:661-664
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mishima Yuko¹²^ORCID,Terui Yasuhito¹²,Yokoyama Masahiro¹,Nishimura Noriko¹,Ueda Kyoko¹,Kusano Yoshiharu¹^ORCID,Yamauchi Hirofumi¹,Inoue Norihito¹,Takahashi Anna¹,Tsuyama Naoko³,Mishima Yuji²,Takeuchi Kengo³⁴,Hatake Kiyohiko¹²

Affiliation:

1. Department of Haematology Oncology; The Cancer Institute Hospital; Japanese Foundation for Cancer Research; Tokyo Japan

2. Division of Clinical Research; The Cancer Chemotherapy Centre; Japanese Foundation for Cancer Research; Tokyo Japan

3. Division of Pathology; The Cancer Institute; Japanese Foundation for Cancer Research; Tokyo Japan

4. Pathology Project for Molecular Targets; The Cancer Institute; Japanese Foundation for Cancer Research; Tokyo Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15001/fullpdf

Reference10 articles.

1. CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy;Ennishi;Annals of Oncology,2008

2. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

3. Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma;Hwang;Blood Research,2013

4. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival;Johnson;Blood,2009

5. Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma;Novak;Blood Cancer Journal,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins;Clinical Proteomics;2023-09-13

3. Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx;Frontiers in Oncology;2022-08-23

4. De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients;Annals of Diagnostic Pathology;2022-06

5. De Novo CD5+ Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances;Clinical Lymphoma Myeloma and Leukemia;2020-10